1. M11 Nintedanib and pirfenidone for idiopathic pulmonary fibrosis (IPF) in north east england – real life data. (12th November 2019) Authors: Murphy, CJ; Donaldson, C; Langlands, L; Wiscombe, S; Simpson, AJ; Forrest, IA Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. M13 From interstitial lung disease (ILD) multidisciplinary team meeting (MDT) to anti-fibrotic medication – review of regional MDT referrals. (12th November 2019) Authors: Murphy, CJ; Donaldson, C; Langlands, L; Wiscombe, S; Simpson, AJ; Forrest, IA Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S11 Improvement of Inspiratory Muscle and One Minute Sit to Stand function associated with Interstitial Lung Diseases pulmonary rehabilitation. (11th November 2022) Authors: Alsomali, H; Chambers, F; McNeillie, L; Alquaimi, M; Donaldson, C; Langlands, L; Hartley, J; Harper, J; Bourke, AM; Ward, C; Forrest, I Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗